Lupin has received final approval to market for its triamcinolone acetonide cream USP, 0.025%, 0.1% and 0.5% from US FDA, a generic equivalent of Mylan Pharmaceuticals' triamcinolone acetonide cream. Lupin shall commence promoting the product shortly.
Lupin's triamcinolone acetonide cream is an AT rated generic equivalent of Mylan Pharma cream and is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
Triamcinolone acetonide cream had US sales of US$ 55.7 million.